Semaglutide (Ozempic, Wegovy) Tirzepatide (Mounjaro, Zepbound) Liraglutide (Victoza) Clinical Studies A February 2026 study found that SGLT2 inhibitors are often associated with a lower 5-year risk of chronic kidney disease progression than GLP-1s, though both offer substantial benefits
who started one in 2021 had stopped within a year, according to a 2024 Scientific American report using data from Epic Research
As a result, some patients report fluctuating tolerance before stabilization occurs
Get Weight Loss Treatment in Redondo Beach GLP-1 medications work by mimicking a natural hormone that helps regulate blood sugar, slow digestion, and curb appetite
When the last injection clears, circulating GLP-1 receptor agonist activity drops to zero, and the central nervous system reverts to its pre-drug set-point within two to four weeks